Frankfurt - Delayed Quote EUR
Galapagos NV (GXE.F)
25.04
-0.20
(-0.79%)
At close: June 3 at 9:49:53 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in EUR | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 3 | 8 | 8 |
| Avg. Estimate | 70.77M | 67.09M | 267.51M | 282.27M |
| Low Estimate | 65M | 55M | 194.7M | 209.1M |
| High Estimate | 76.2M | 73.5M | 294.58M | 360.12M |
| Year Ago Sales | 77.87M | 59.85M | 275.65M | 267.51M |
| Sales Growth (year/est) | -9.13% | 12.10% | -2.95% | 5.52% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GXE.F | -- | -- | -- | -- |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Related Tickers
25I.SG ImmuPharma PLC
0.0250
+19.05%
BCX.WA Bioceltix S.A.
101.60
-2.68%
IMR.BE AC Immune SA
1.4720
+1.24%
22Z.SG Zealand Pharma A/S
59.92
-0.20%
8EM.BE Editas Medicine Inc
1.4920
+2.72%
0M4.F Mersana Therapeutics, Inc.
0.2505
-9.60%
2LB.MU Iovance Biotherapeutics Inc
1.5420
0.00%
GYX.F Futura Medical plc
0.0865
-31.89%
9WV.BE Nutriband Inc
6.90
+21.05%
RXK3.MU SELLAS Life Sciences Group Inc
1.3930
-5.04%